This document provides a comparison of herbal monographs from three pharmacopoeias: the Ayurvedic Pharmacopoeia of India (API), British Herbal Pharmacopoeia (BHP), and American Herbal Pharmacopoeia (AHP). It outlines the typical contents of monographs from each, such as definitions, descriptions, chemical assays, and qualitative standards. The API focuses on ayurvedic herbs, while the BHP and AHP include Western and traditional medicine herbs. The AHP contains the most therapeutic information, while the API and BHP emphasize identification and purity. Harmonizing formats across pharmacopoeias can help ensure the quality, safety and efficacy of herbal medicines.
In this slide contains Introductionnof Indian pharmacopeia, ayurvedic, unani pharmacopeia and monographs of herbal drugs.
Presented by: P.SUDHEER KUMAR (Department of pharmaceutical analysis ).RIPER, anantapur
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Standardization of herbal drugs refers to “confirmation of its identity and determination of its quality, purity and detection of nature of adulterant by various parameters”.
In this slide contains Introductionnof Indian pharmacopeia, ayurvedic, unani pharmacopeia and monographs of herbal drugs.
Presented by: P.SUDHEER KUMAR (Department of pharmaceutical analysis ).RIPER, anantapur
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Standardization of herbal drugs refers to “confirmation of its identity and determination of its quality, purity and detection of nature of adulterant by various parameters”.
In this slide contains Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American Herbal Pharmacopoeia.
Presented by: M.SUDHEESHNA (Department of pharmaceutical analysis ).RIPER, anantapur
Regulatory requirement for setting herbal drug industryRAGHAV DOGRA
The World Health Organization (WHO) estimates that 80 percent of the population of some Asian and African countries presently use herbal medicine for some aspect of primary health care.Pharmaceuticals are prohibitively expensive for most of the world's population, half of whom lived on less than $2 U.S. per day in 2002. In comparison, herbal medicines can be grown from seed or gathered from nature for little or no cost
patent (/ˈpætənt/ or /ˈpeɪtənt/) is a set of exclusive rights granted by a sovereign state to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. An invention is a solution to a specific technological problem and is a product or a process. Patents are a form of intellectual property.
Regulatory requirements for herbal medicines: Herbal medicines are different from other types of medicines. The approval process is also different from other medicines. AYUSH Ministry given guidelines for approval of herbal medicines.
Query Solved
1. Regulatory requirements for herbal medicines
2. Herbal Medicines ke liye regulatory requirements
3. AYUSH ka important role in Herbal medicines launch
4. D and C act role in Herbal medicines
5. What are important steps to launch herbal medicines
Herbal drugs are usually considered safe but when taken along with other drugs of chemical origin (allopathic drugs), they do interact with them and cause Bio-drug interaction
In this power points viewer will be able to know the meaning of Pharmacopoeia and its coposition. History behind the different pharmacopoeia and popular pharmacopoeia existing world wide in herbal medicines. List of different pharmacopoeias also has been included.
MICROBIAL CONTAMINATION IN HERBS AND THEIR FORMULATIONSVK VIKRAM VARMA
INTRODUCTION
SOURCES OF CONTAMINATION
RAW MATERIALS
PACKAGING MATERIALS
LIMITS FOR MICROBIAL CONTAMINATION
LIMITS AS PER WHO
TYPES OF CONTAMINATION
DIRECT CONTAMINATION
CROSS CONTAMINATION
DETERMINATION OF CONTAMINATION
TOTAL VIABLE COUNT
PRETREATMENT OF HERBAL MATERIALS
REFRENCES
Quality assurance (QA) is a way of preventing mistakes and defects in manufactured products and avoiding problems when delivering products or services to customers.
Description about what is pharmacopoeia? different pharmacopoeia and there edition. What is monograph and there comparative studies in different pharmacopoeias along with monograph format in per different pharmacopoies.
In this slide contains Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American Herbal Pharmacopoeia.
Presented by: M.SUDHEESHNA (Department of pharmaceutical analysis ).RIPER, anantapur
Regulatory requirement for setting herbal drug industryRAGHAV DOGRA
The World Health Organization (WHO) estimates that 80 percent of the population of some Asian and African countries presently use herbal medicine for some aspect of primary health care.Pharmaceuticals are prohibitively expensive for most of the world's population, half of whom lived on less than $2 U.S. per day in 2002. In comparison, herbal medicines can be grown from seed or gathered from nature for little or no cost
patent (/ˈpætənt/ or /ˈpeɪtənt/) is a set of exclusive rights granted by a sovereign state to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. An invention is a solution to a specific technological problem and is a product or a process. Patents are a form of intellectual property.
Regulatory requirements for herbal medicines: Herbal medicines are different from other types of medicines. The approval process is also different from other medicines. AYUSH Ministry given guidelines for approval of herbal medicines.
Query Solved
1. Regulatory requirements for herbal medicines
2. Herbal Medicines ke liye regulatory requirements
3. AYUSH ka important role in Herbal medicines launch
4. D and C act role in Herbal medicines
5. What are important steps to launch herbal medicines
Herbal drugs are usually considered safe but when taken along with other drugs of chemical origin (allopathic drugs), they do interact with them and cause Bio-drug interaction
In this power points viewer will be able to know the meaning of Pharmacopoeia and its coposition. History behind the different pharmacopoeia and popular pharmacopoeia existing world wide in herbal medicines. List of different pharmacopoeias also has been included.
MICROBIAL CONTAMINATION IN HERBS AND THEIR FORMULATIONSVK VIKRAM VARMA
INTRODUCTION
SOURCES OF CONTAMINATION
RAW MATERIALS
PACKAGING MATERIALS
LIMITS FOR MICROBIAL CONTAMINATION
LIMITS AS PER WHO
TYPES OF CONTAMINATION
DIRECT CONTAMINATION
CROSS CONTAMINATION
DETERMINATION OF CONTAMINATION
TOTAL VIABLE COUNT
PRETREATMENT OF HERBAL MATERIALS
REFRENCES
Quality assurance (QA) is a way of preventing mistakes and defects in manufactured products and avoiding problems when delivering products or services to customers.
Description about what is pharmacopoeia? different pharmacopoeia and there edition. What is monograph and there comparative studies in different pharmacopoeias along with monograph format in per different pharmacopoies.
Comparison of various herbal pharmacopoeias.pptxEasy Concept
Herbal Pharmacopoeia is a reference book for the preparation of quality medicines published by the authority of a Government and represents qualitative and therapeutic monographs on botanicals
Monographs of herbal drugs: General parameters of
monographs of herbal drugs and comparative study in IP, USP,
Ayurvedic Pharmacopoeia, Siddha and Unani Pharmacopoeia,
American herbal pharmacopoeia, British herbal pharmacopoeia,
WHO guidelines in quality assessment of herbal drugs.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Monographs Of Herbal Drugs and Comparative Study In Various Pharmacopoeias.
1. JSS Academy of Higher Education & Research
(Deemed to be University)
Accredited ‘A’ Grade by NAAC
Sri Shivarathreeshwara Nagara, Mysuru – 570 015
Karnataka, INDIA
MONOGRAPHS FOR HERBAL DRUGS
AND COMPARATIVE STUDY IN
AMERICAN & BRITISH HERBAL
PHARMACOPOEIA.
Presented By:
V. Vidya Dhari
SUB: HERBAL AND COSMETIC
ANALYSIS
GPRCP
2. CONTENTS
Monograph introduction
Definition
Purpose of monograph
Importance of content of monograph
Introduction of various herbal monographs and
guidelines- IP,API.
Comparative study of
1. American herbal pharmacopoeia.
2. British Herbal Pharmacopoeia.
3. Herbal monographs in national pharmacopoeias and other
authorative documents play an important role in the authentication
of herbal materials.
In this context a monograph is a document that defines a
botanical drug and provides information that allows for its proper
identification.
The herbal monographs give a basic description of the herb, and
list its chemical constituents, actions, clinical uses and recommended
dosage etc.
Introduction
4. The purpose of the monographs is to:
Provide scientific information on the safety, efficacy, and quality
control/ quality assurance of widely used medicinal plant.
Provide models to assist Member States in developing their own
monographs or formularies for these or other herbal medicines.
Facilitate information exchange among Member States.
The goal of the monograph project is to protect those who have an
interest in traditional medicines (patient, prescriber, pharmacist,
manufacturer, health authority, medicines regulatory body) against
medicine of poor quality.
6. Botanical features
Distribution
Identity tests
Purity requirements
Chemical assay
Chemical constituents
Example: USP Standards Monographs
6
STANDARD MONOGRAPH
7. Definition Of The Plant Drug
Clinical applications
Pharmacology
Contraindications
Warnings
Precautions
Potential adverse reactions
Posology ( Form of administration, Duration of use )
Examples: ESCOP (The European Scientific Cooperative On Phytotherapy)
monographs
7
THERAPEUTIC MONOGRAPH
8. COMBINED MONOGRAPH
Standard monograph + Therapeutic monograph =
Combined monograph.
Examples:
1. WHO (World Health organization) monographs
2.AHP (American Herbal Pharmacopeia)
monographs
8
9. IMPORTANCE OF CONTENT OF
THE MONOGRAPHS
DEFINITION
SYNONYMSANDVERNACULARNAMES
DESCRIPTION
1.Macroscopy
2.Microscopy
GEOGRAPHICALDISTRIBUTION
MAJORCHEMICALCONSTITUENTS
IDENTITY,PURITYANDSTRENGTH
-Itincludesforeignmatterandquantitativetests.
• TheQuantitativetests
Total ash
Acid-insoluble ash
10. Water soluble ash
Bitterness value
Loss on drying;
Water content;
Volatile oils, etc.,
PHARMACOLOGy
CLINICAL STUDY
TOXICOLOGY
SAFETY
ADVERSE DRUG REACTION
CHROMATOGRAPHIC AND SPECTROSCOPIC EVALUATION
11. MONOGRAPHS OF PHARMACOPOEIA
• Indian Pharmacopoeia
• United states of Pharmacopoeia
• Ayurvedic Pharmacopoeia of India
• Siddha Pharmacopoeia
• Unani Pharmacopoeia
• American Herbal Pharmacopeia
• British Herbal Pharmacopoeia
12. INDIAN PHARMACOPOEIA
First official Pharmacopeia of India appeared in 1868 which was edited
by Edward John Waring.
In preindependence days, British Pharmacopeia was used in India.
In 1946 Government of India issued one list known as „The Indian
Pharmacopeial List.,Committee under chairmanship of Sir R. N. Chopra
along with other nine members prepared „The Indian Pharmacopeiallist”.
It was prepared by Dept. of Health, Govt. of India, Delhi in 1946.
In 1948 Government of India appointed an Indian Pharmacopeia
committee for preparing „Pharmacopeia of India‟Tenure of this committee
was five years.
Indian Pharmacopeia committee under chairmanship of Dr. B. N. Ghosh
Published first edition of IP in 1955.
13. Salient features of IP 2018
General chemical test,TLC, IR, UV, HPLC has been given.
Pyrogen test replaced by bacterial endotoxin test (BET) in parenteral
preparations.
Index is incorporated in all volumes.
Chapters on volumetric glasswares conductivity,dissolutiontest,
disintegration test,dimensions of hard gelatin capsule were revised.
53 new fixed dose combinations included,out of which 25 are not available
in any pharmacopoeia.
General chapters on maintenance, identification ,preservation and disposal
of microrganism have been included.
14. AYURVEDIC PHARMACOPOEIA OF INDIA
It is the legal document of standards for the quality of ayurvedic drugs and the
substance include therein. (Under the drug & cosmetic act, 1940).
API came in existence in 1962.
It was published in 1989.
API has worked out monographs on the basis of genuine and authentic drug
samples approved by the physician, manufacturing experts, and other expertise on
the subject.
At present about 1000 single drugs and 8000 compound formulations are used in
Ayurveda system including drugs of plants, animal and mineral origin in both single
and compound formulation.
14
15. Part 2 : Vol 1
Vol 2
These all monographs deals with the pharmacognostical, chemical and
ayurvedic standards of the plant drugs which are used in ayurveda.
15
Part 1
Deals with formulation.
Volume No. of
monographs
Year
1 80 (1986)
2 78 (1999)
3 100 (2001)
4 68 (2004)
5 84 (2006)
6 101 2008
7 21 2008
8 60 2010
16. API MONOGRAPH
1. Monograph title- Sanskrit
2. Introductory para
3. Synonym- English and Urdu
4. Description
5. Identity, Purity and Strength
6. Physico-chemical parameters- TLC etc
7. Properties of action
8. Important formulation and therapeutic uses
9. Doses-metric system
10. For compound formulations
- Method of preparations
- Storage
- Physicochemical parameters
18. BRITISH HERBAL PHARMACOPOEIA
The UK founded British Herbal Medical Association (BHMA) in 1964 to
advance the science and practice of herbal medicines in order to ensure its
statutory recognition.
First British Herbal Pharmacopoeia (BHP) was published by BHMA in 1971
giving monographs and quality control tests for some of the common herbs and
herbal products in the UK,
Revised in 1990
1990
1996
18
84 monographs
169 monographs
19. In 1992 BHMA published a companion British Herbal Compendium, volume I,
which gives therapeutic monographs on the same 84 herbs.
BHP mainly paid attention on developing TLC techniques for comparative
identification of new botanical drugs.
19
20. Basic format of a BHP monograph
Characteristics
Macroscopical and microscopical descriptions of the
herbal material.
Identification
Quantitative Standards
include limits for foreign matter, loss on drying,
total and/or acid-insoluble ash, amounts of solvent extractives and
volatile oil.
Material of Commerce
A brief description of the form of the material and
its main geographical sources.
Powdered Material
A description of characteristic macroscopical
and microscopical features.
22. AMERICAN HERBAL PHARMACOPOEIA
The primary goal of the AHP is to produce authoritative herbal monographs
containing accurate, critically reviewed information on botanicals which can
provide guidance in the appropriate use of herbal therapeutics."
The AHP began developing qualitative and therapeutic monographs in 1994,
and intends to produce 300 monographs on botanicals, including many of the
ayurvedic, Chinese and western herbs.
The AHP monographs are combined monographs; they include much of the
standard definitional and analytical information found in conventional
pharmacopeial monographs on standards, plus therapeutic and clinical
information.
22
23. Plant examples
Ashwagandha root
Astragalus root
Bilberry fruit
Black cohosh rhizomes
Chaste tree fruit
Cramp bark
Valerian root
Ginko leaf
Echinacea purpurea root
23
28. 1. The Ayurvedic Pharmacopoeia of India, First Edition,
Government of India, New Delhi 2006.
2. Journal of American Botanical Council, 1997, issue no. 40, pg. 30
3. www.herbal.ahp.org
4. http://europa.eu/agencics/commenity_agencies.htm
5. www.Bhma.info/publication?index.html
28
REFERENCES